Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Neurotrope Inc (NQ: NTRP )

0.9410 USD UNCHANGED
Last Price Updated: 6:44 PM EST, Dec 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Neurotrope Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials
Synaptogenix, Inc. (OTC: SNPX) announced today that it has received its first batch of synthetic Bryostatin. The Company has an exclusive licensing agreement with Stanford University ("Stanford") for... 
From PR Newswire
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
- Petros to Grow and Pursue Non-Prescription / Over-The-Counter ("OTC") Strategies for FDA-Approved Erectile Dysfunction Drug Therapy 
From PR Newswire
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates
Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with Metuchen Pharmaceuticals 
From PR Newswire
Insider Buys Neurotrope Stock
Neurotrope Inc (NASDAQ:NTRP) was trading 1.10% higher from the previous closing price. A Form 4 filing filed with the SEC on ... 
Tags Benzinga Insider Trade Market News
From Benzinga
Insider Buys Neurotrope's Stock
Neurotrope Inc (NASDAQ:NTRP) was trading 3.6% higher from the previous closing price. A Form 4 filing filed with the SEC on Monday, ... 
Tags News Insider Trades Markets
From Benzinga
Insider Buys Neurotrope Stock
A Form 4 filing filed with the SEC on Thursday, October 22 showed that Schechter Jonathan bought 2,012 shares of Neurotrope Inc ... 
Tags NTRP Markets Intraday Update
From Benzinga
Top Buys by Directors: Silverman's $107.8K Bet on NTRP
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... 
Tags Stocks
From Market News Video
Insider Buys Neurotrope's Stock
Neurotrope Inc (NASDAQ:NTRP) was trading 2.1% higher from the previous closing price. A Form 4 filing filed with the SEC on Tuesday, ... 
Tags Market News Insider Trade Benzinga
From Benzinga
Monday 10/19 Insider Buying Report: KRON, NTRP
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. 
Tags Stocks
From Market News Video
Insider Buys Neurotrope's Shares
Neurotrope Inc (NASDAQ:NTRP) was trading 4.6% higher from the previous closing price. Silverman Joshua filed a Form 4 with the SEC on ... 
Tags News Insider Trades Markets
From Benzinga
Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease
- Study Being Conducted in Collaboration with NIH Under a $2.7 Million Grant - 
From PR Newswire
Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen
Neurotrope Shareholders, Currently Representing 34 Percent of Shares Outstanding, Sign Agreement in Support of Merger 
From PR Newswire
Hercules Capital Reports Second Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of... 
From Business Wire News Releases
Neurotrope Bioscience Announces Agreement with Worldwide Clinical Trials, to Conduct Ongoing Phase 2 Study of Bryostatin-1, Partially Funded by NIH, for Alzheimer's Disease
Neurotrope, Inc. (Nasdaq: NTRP) ("Neurotrope" or the "Company") today announced that its wholly-owned subsidiary, Neurotrope Bioscience, Inc. ("NBI"), has entered into a services agreement with... 
From PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - FNJN, NTRP, GRUB
From ACCESSWIRE
Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute (NCI) Trial for Childhood Leukemia
- Neurotrope and Metuchen continue to move toward closing the previously announced merger 
From PR Newswire
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
BryoLogyx announces agreements with Neurotrope to acquire bryostatin-1 immuno-oncology data package and supply synthetic bryostatin-1 
From Business Wire News Releases
Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease
- New Phase 2 Study to Be Conducted in Collaboration with NIH Under a $2.7 Million Grant - 
From PR Newswire
Neurotrope Announces Investor Update Conference Call
- Management to Host Investor Conference Call on Thursday, May 28, at 11:00 AM ET - 
From PR Newswire
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - WMGI, MINI, NTRP
From ACCESSWIRE
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
Lead asset Stendra® (avanafil) Looks to Build on $25 Million of 2019 Gross Sales 
From PR Newswire
XpresSpa Appoints Robert Weinstein to Board of Directors
From GlobeNewswire News Releases
43 Healthcare Stocks Moving In Tuesday's After-Market Session
Gainers Hepion Pharmaceuticals, Inc.(NASDAQ: HEPA) shares surged 37.5% to $6.85 during Tuesday's after-market ... 
Tags ARAY CAPR OTLK
From Benzinga
Why I Love Trading A Small Account, And Why You Should Too
January is turning out to be a bit of a roller-coaster market for my main account. After a couple of frustrating days last week, I was ... 
Tags Benzinga Side Hustle Challenge ICCC
From Benzinga
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
Financialnewsmedia.com News Commentary 
From PR Newswire
26 Biotechnology Stocks Moving In Wednesday's After-Market Session
Gainers • Innovate, Inc. (NASDAQ:INNT) stock rose 29.2% to $0.85 during Wednesday's after-market session. • Genprex, ... 
Tags SRRA Biotechnology Stocks Biotechnology Stocks After/Market Movers JAGX
From Benzinga
36 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers • Innovate, Inc. (NASDAQ:INNT) stock surged 29.2% to $0.85 during Wednesday's after-market session. • ... 
Tags SLDB GNPX ALEC
From Benzinga
Mid-Afternoon Market Update: FuelCell Energy Falls On Downbeat Q4 Results; Neurotrope Shares Rise
Toward the end of trading Wednesday, the Dow traded up 0.28% to 29,278.63 while the NASDAQ rose 0.57% to 9,424.49. The S&P also ... 
Tags Commodities Eurozone NVAX
From Benzinga
Neurotrope, Inc. Announces $18 Million Registered Direct Offering
Neurotrope, Inc. (the "Company") (NASDAQ:NTRP) today announced that it has received commitments from institutional investors and pre-existing high net worth individuals to purchase an aggregate of $18... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.